IFNG and type 1 diabetes mellitus: An altered-peptide ligand of the insulin B chain 9–23 epitope administered s.c. to recent onset T1D subjects reduces peptide-specific IFNγ-secreting Teff, while elevating Th2-like aTreg (211, 212).